hydroxyindoleacetic acid has been researched along with dacarbazine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moertel, CG | 1 |
| Leonhardt, U; Ramadori, G; Ritzel, U; Stöckmann, F | 1 |
| Cubeddu, LX; Hoffmann, I; O'Connor, DT; Parmer, RJ | 1 |
| Bodoky, G; Pregun, I; Rácz, K; Tulassay, Z | 1 |
2 review(s) available for hydroxyindoleacetic acid and dacarbazine
| Article | Year |
|---|---|
Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Carcinoid Tumor; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Embolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Ligation; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Middle Aged; Rectal Neoplasms; Streptozocin; Tamoxifen | 1983 |
[Carcinoid tumors].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Biomarkers, Tumor; Bronchial Neoplasms; Carcinoid Tumor; Chromogranin A; Clinical Trials as Topic; Dacarbazine; Early Detection of Cancer; Gastrointestinal Neoplasms; Heterocyclic Compounds; Humans; Hydroxyindoleacetic Acid; Lung Neoplasms; Organometallic Compounds; Prevalence; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Somatostatin; Temozolomide; Thalidomide; TOR Serine-Threonine Kinases; Treatment Outcome | 2010 |
2 other study(ies) available for hydroxyindoleacetic acid and dacarbazine
| Article | Year |
|---|---|
Treatment of metastasized midgut carcinoids with dacarbazine.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoid Tumor; Dacarbazine; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Infusions, Intravenous; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Treatment Outcome | 1995 |
Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.
Topics: Adult; Antineoplastic Agents; Chromogranin A; Chromogranins; Cyclophosphamide; Dacarbazine; Female; Humans; Hydroxyindoleacetic Acid; Male; Mechlorethamine; Middle Aged; Serotonin; Vomiting | 1995 |